Trends in the treatment of pelvic malignant diseases.
D002277:Carcinoma / Q000628:therapy; D002699:Chlorambucil / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D005833:Genital Neoplasms, Female / Q000628:therapy*; D006801:Humans; D007044:Hysterectomy; D008197:Lymph Node Excision; D008558:Melphalan / Q000627:therapeutic use; D010051:Ovarian Neoplasms / Q000188:drug therapy; D011372:Progestins / Q000627:therapeutic use; D011882:Radiotherapy, High-Energy; D013852:Thiotepa / Q000627:therapeutic use; D002583:Uterine Cervical Neoplasms / Q000401:mortality / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy; D014594:Uterine Neoplasms / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy
D011372:Progestins; D002699:Chlorambucil; D003520:Cyclophosphamide; D013852:Thiotepa; D008558:Melphalan